ARCHIVES

NCI advisors seek comment on clinical trials system, until Jan. 15.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

Pathology In Operating Suite Cuts Need for More Surgery

February 24, 2012

SWOG Closes Prostate Cancer Trial With Mitoxantrone

February 23, 2007

NSABP Objects to “Closed Process” For Review Of P-4 Breast Cancer Chemoprevention Trial.

April 20, 2007

NCI Planning To Switch Drug Development Emphasis From Compound To Human Cancer Oriented Strategy

October 26, 1984

Two New Communications Contracts Approved

October 18, 1985

ODAC Recommends Taxol For Metastatic Breast Cancer

January 7, 1994